MYCN and neoplasm: Over the past three decades, tumor histology (6, 7), status of the MYCN oncogene (8, 9), and tumor cell DNA content (ploidy) (10, 11) have each been shown to be independently predictive of patient outcome in large retrospective and prospective studies.